CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes

Stopped The study was terminated after the recruitment had been completed due to a decision to discontinue development of CK-0045

Conditions

• Type 2 Diabetes Mellitus (T2DM)
• Obesity and Overweight

Interventions

• DRUG: CK-0045
• DRUG: Placebo

Sponsor

Cytoki Pharma

Collaborators

• [object Object]
• [object Object]